Five-Years Tigecycline Experience an Analysis of Real-Life Data [PDF]
Aim: Tigecycline has been approved by the Food and Drug Administration for the treatment of complicated intra-abdominal infections, skin and soft tissue infections and community-acquired pneumonia.
Fatih Temocin +8 more
doaj +2 more sources
KPC-producing Klebsiella pneumoniae isolates have emerged as important pathogens of nosocomial infections, and tigecycline is one of the antibiotics recommended for severe infections caused by KPC-producing K. pneumoniae.
Fang He +6 more
doaj +2 more sources
The first tigecycline resistant Enterococcus faecium in Norway was related to tigecycline exposure [PDF]
: Objectives: We describe the first tigecycline resistant enterococcal isolate in Norway and the mechanisms involved. Material and methods: The Norwegian National Advisory Unit on Detection of Antimicrobial Resistance (K-res).
Kristin Hegstad +4 more
doaj +3 more sources
Xiaoxia Li,1,* Junnian Liu,2,* Xinyu Zhang,1 Juan Li,3 Luhan Xuan,1 Sue Yuan,1 Jianglin Li,1 Yu Sun,1 Xuefei Du1 1Clinical Laboratory, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People’s Republic of
Li X +8 more
doaj +2 more sources
Tigecycline Treatment In Critically Ill Children: A Single-Center Experience
AIM: We aimed to draw attention to the fact that tigecycline may be an alternative in the treatment of resistant gram-negative infections in children.
Neslihan Mete Atasever +4 more
doaj +2 more sources
Immunomodulatory Effects of Tigecycline in Balb/C Mice
Tigecycline is a glycylcycline antibiotic approved by the FDA for the treatment of complicated infections. Despite its effectiveness, the FDA announced a warning of increasing mortality associated with its use. There is, however, no clear explanation for
Elhayek Shada Y. +4 more
doaj +2 more sources
Structural basis for differential inhibition of eukaryotic ribosomes by tigecycline
Tigecycline is widely used for treating complicated bacterial infections for which there are no effective drugs. It inhibits bacterial protein translation by blocking the ribosomal A-site.
Xiang Li +6 more
doaj +2 more sources
Antimicrobial Photodynamic Therapy With New Methylene Blue and Its Combined Effect With Antibiotics Against MDR Acinetobacter baumannii. [PDF]
NMB‐mediated aPDT significantly inhibited MDR A. baumannii and enhanced the efficacy of tigecycline and colistin through synergistic or additive interactions. Increased ROS generation during aPDT and combination therapy may contribute to the observed antibacterial effects.
Barati B +4 more
europepmc +2 more sources
Antibiotic Resistance and Biofilm Gene Distribution in Colistin-Resistant Acinetobacter baumannii. [PDF]
Multicenter analysis of 144 clinical Acinetobacter baumannii isolates in Iran revealed high MDR/XDR rates and widespread biofilm formation (90.9%). Colistin resistance was linked to pmrAB overexpression, while blaPER‐1 was independently associated with strong biofilm production, highlighting chromosomal resistance mechanisms and biofilm as key drivers ...
Hatem ZA +7 more
europepmc +2 more sources
Hospital-Associated Antimicrobial Resistant Bacteria on 95 Mobile Phones: An International Metagenomic "Phonome" Analysis. [PDF]
On average, phones harbored 3.62 of the top 10 killers and 2.49 ESKAPE organisms. In total, 667 VFGs (8621 Hits) and 262 ARGs (2475 Hits) were identified on 95 mobile phones. Mobile phones serve as a platform for horizontal gene transfer and AMR development.
Goldsworthy A +12 more
europepmc +2 more sources

